10x Genomics Inc (TXG)
10.90
-0.66
(-5.75%)
USD |
NASDAQ |
Feb 21, 16:00
10.98
+0.08
(+0.78%)
After-Hours: 20:00
Key Stats
Price and Performance | |
---|---|
Market Cap | 1.332B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -75.64% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | 2.149 |
Price to Book Value | 1.876 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.00 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 93.49% |
Profile
Edit
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China). |
URL | https://www.10xgenomics.com |
Investor Relations URL | https://investors.10xgenomics.com/ |
HQ State/Province | California |
Sector | Health Care |
Industry | Life Sciences Tools & Services |
Next Earnings Release | Apr. 30, 2025 (est.) |
Last Earnings Release | Feb. 12, 2025 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Edit
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China). |
URL | https://www.10xgenomics.com |
Investor Relations URL | https://investors.10xgenomics.com/ |
HQ State/Province | California |
Sector | Health Care |
Industry | Life Sciences Tools & Services |
Next Earnings Release | Apr. 30, 2025 (est.) |
Last Earnings Release | Feb. 12, 2025 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |